Miracell Selected as an Innovative Company in the Health and Diagnostics Sector
Stem cell specialist Miracell (CEO Shin Hyun-soon) announced on the 1st that it has been selected as one of the government’s “1,000 Innovative Companies.”
The “1,000 Innovative Companies” program, organized by nine ministries including the Ministry of Trade, Industry and Energy, the Ministry of SMEs and Startups, the Ministry of Science and ICT, the Ministry of Health and Welfare, and the Ministry of Oceans and Fisheries, selects leading innovative companies by industry.
This program aims to foster these companies as future core businesses through innovative financial support.
Starting with 32 companies selected in the first round, 247 companies were selected in the second round, and 321 companies were selected in the third round.
Miracell Selected as an Innovative Company in the Health and Diagnostics Sector
Miracell was selected as one of the “Innovative Companies in the Health and Diagnostics Sector” in the fields of new health technologies, medical devices, and innovative pharmaceuticals, based on selection criteria established by the Ministry of Health and Welfare.
This company, a stem cell specialist launched in 2009 by adopting Harvard University’s cell extraction technology,
succeeded in developing the “Minimum Manipulation Stem Cell Isolation and Amplification Source Technology” in 2017, and the Ministry of SMEs and Startups selected this technology as a small business commercialization technology development project.
Based on this technology, the company independently developed and successfully domestically produced the Smart Mcell 2. The Smart Mcell 2 extracts bone marrow blood, concentrates it through centrifugation, and automatically separates a large quantity of stem cells. It is currently used in major hospitals both domestically and internationally.
Its unique feature is its automated, closed system, which prevents air contact and prevents cell deformation.
The Smart Mcell 2 is equipped with a special LED to enhance cell activity, converting the existing analog method to digital. It also features voice support,
making it a highly regarded, cutting-edge bio-healthcare medical device.